Royal Bank of Canada
COCH icon

Royal Bank of Canada’s Envoy Medical COCH Stock Holding History

Royal Bank of Canada’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,698
Closed -$4K – 6927
2024
Q2 		$4K Hold
1,698
– – ﹤0.01% 6575
2024
Q1 		$7K Buy
+1,698
New +$4.97K ﹤0.01% 6317

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Royal Bank of Canada's COCH Position: Q3 2024 in Review

Royal Bank of Canada sold out of Envoy Medical (COCH) in Q3 2024, closing a stake of 1,698 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in COCH in Q1 2024 and held it in 2 quarters. The position peaked at $7K in Q1 2024. 18 funds tracked by Wall St. Rank hold COCH as of Q3 2024.

  • Royal Bank of Canada reported no remaining Envoy Medical position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 1,698 Envoy Medical shares in Q3 2024, an estimated $4K.
  • Royal Bank of Canada first reported a position in Envoy Medical in Q1 2024 and held it in 2 quarters.
  • Royal Bank of Canada's Envoy Medical position peaked at $7K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.